VTR:NYE-Ventas Inc. (USD)

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 66.85

Change

-0.11 (-0.16)%

Market Cap

USD 21.02B

Volume

2.85M

Analyst Target

USD 38.42
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ventas Inc is a real estate investment trust. The Company has diversified portfolio of seniors housing and healthcare properties located throughout the United States, Canada and the United Kingdom.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

-1.74 (-1.16%)

USD 88.79B
DOC Healthpeak Properties Inc

-0.03 (-0.15%)

USD 13.70B
CTRE CareTrust REIT Inc.

-0.69 (-2.69%)

USD 5.04B
AHR American Healthcare REIT, Inc.

-0.56 (-2.01%)

USD 4.42B
NHI National Health Investors Inc

-0.80 (-1.15%)

USD 3.08B
LTC LTC Properties Inc

-0.17 (-0.49%)

USD 1.54B
CHCT Community Healthcare Trust Inc

-0.14 (-0.74%)

USD 0.56B
UHT Universal Health Realty Income..

-0.29 (-0.74%)

USD 0.54B
GMRE-PA Global Medical REIT Inc

-0.06 (-0.22%)

USD 0.41B
GMRE Global Medical REIT Inc

-0.03 (-0.36%)

N/A

ETFs Containing VTR

BYRE Principal Exchange-Traded.. 8.59 % 0.00 %

-0.28 (-0.95%)

USD 0.01B
SRHR Elevation Series Trust 6.49 % 0.00 %

-0.55 (-0.95%)

USD 0.05B
WNEW:LSE WisdomTree New Economy Re.. 5.92 % 0.00 %

-0.20 (-0.95%)

N/A
WTRE:LSE WisdomTree New Economy Re.. 5.92 % 0.00 %

-0.01 (-0.95%)

N/A
JPRE JPMorgan Realty Income ET.. 5.31 % 0.00 %

-0.38 (-0.95%)

USD 0.41B
WTRE WisdomTree New Economy Re.. 5.00 % 0.00 %

-0.17 (-0.95%)

USD 0.01B
WTRE:XETRA 4.97 % 0.00 %

N/A

N/A
WTER:XETRA 4.97 % 0.00 %

N/A

N/A
WNER:LSE WisdomTree New Economy Re.. 4.91 % 0.00 %

+0.01 (+-0.95%)

USD 1.32M
WTNR:LSE WisdomTree New Economy Re.. 4.91 % 0.00 %

-0.80 (-0.95%)

USD 3.73M
JRE Janus Henderson U.S. Real.. 4.19 % 0.00 %

-0.27 (-0.95%)

USD 0.03B
RSPR Invesco S&P 500 Equal Wei.. 3.32 % 0.00 %

-0.19 (-0.95%)

USD 0.11B
DJRE:AU SPDR Dow Jones Global Rea.. 2.66 % 0.00 %

+0.03 (+-0.95%)

USD 0.43B
RENT:AU 2.03 % 0.00 %

N/A

N/A
GBRE:SW SPDR® Dow Jones Global R.. 1.76 % 0.00 %

-0.02 (-0.95%)

USD 0.26B
GLRA:SW SPDR® Dow Jones Global R.. 1.76 % 0.00 %

N/A

USD 0.04B
CVY Invesco Zacks Multi-Asset.. 0.00 % 0.65 %

-0.38 (-0.95%)

USD 0.12B
DRW 0.00 % 0.58 %

N/A

N/A
EWRE 0.00 % 0.40 %

N/A

N/A
REZ iShares Residential and M.. 0.00 % 0.48 %

-0.51 (-0.95%)

USD 0.83B
OLD 0.00 % 0.50 %

N/A

N/A
WREI 0.00 % 0.32 %

N/A

N/A
SPYJ:XETRA 0.00 % 0.00 %

N/A

N/A
CGRE:CA CI Global REIT Private Po.. 0.00 % 0.00 %

N/A

CAD 0.06B
SPY2:XETRA 0.00 % 0.00 %

N/A

N/A
TREG:LSE VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

-0.01 (-0.95%)

USD 0.31B
TRET:LSE VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

-0.05 (-0.95%)

USD 0.31B
SPY2:F 0.00 % 0.00 %

N/A

N/A
GLRA:LSE SPDR® Dow Jones Global R.. 0.00 % 0.00 %

-0.01 (-0.95%)

USD 0.04B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.52% 87% B+ 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.52% 87% B+ 91% A-
Trailing 12 Months  
Capital Gain 51.62% 86% B+ 93% A
Dividend Return 4.08% 14% F 61% D-
Total Return 55.70% 86% B+ 93% A
Trailing 5 Years  
Capital Gain 6.13% 85% B 51% F
Dividend Return 14.83% 23% F 50% F
Total Return 20.96% 69% C- 47% F
Average Annual (5 Year Horizon)  
Capital Gain 11.37% 79% B- 67% D+
Dividend Return 15.11% 79% B- 71% C-
Total Return 3.74% 21% F 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 31.35% 14% F 33% F
Risk Adjusted Return 48.21% 57% F 61% D-
Market Capitalization 21.02B 90% A- 93% A

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.00 11% 1%
Price/Book Ratio 2.64 33% 34%
Price / Cash Flow Ratio 21.87 40% 16%
Price/Free Cash Flow Ratio 21.29 33% 16%
Management Effectiveness  
Return on Equity 0.84% 40% 31%
Return on Invested Capital 19.98% 100% 86%
Return on Assets 1.61% 40% 42%
Debt to Equity Ratio 125.48% 10% 28%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector